TumCMig Cancer Research Results

TumCMig, Tumor cell migration: Click to Expand ⟱
Source:
Type:
Tumor cell migration is a critical process in cancer progression and metastasis, which is the spread of cancer cells from the primary tumor to distant sites in the body.


Scientific Papers found: Click to Expand⟱
60- QC,  EGCG,  isoFl,    The dietary bioflavonoid quercetin synergizes with epigallocathechin gallate (EGCG) to inhibit prostate cancer stem cell characteristics, invasion, migration and epithelial-mesenchymal transition
- in-vitro, Pca, pCSCs
Casp3↑, Casp7↑, Bcl-2↓, survivin↓, XIAP↓, EMT↓, Slug↓, Snail↓, β-catenin/ZEB1↓, LEF1↓, CSCs↓, Apoptosis↑, TumCMig↓, TumCI↓, CD44↓, CD133↓,
53- QC,    Quercetin regulates β-catenin signaling and reduces the migration of triple negative breast cancer
- in-vitro, BC, MDA-MB-231 - NA, NA, MDA-MB-468
E-cadherin↑, Vim↓, cycD1/CCND1↓, cMyc↓, EMT↓, TumCG↓, TumCMig↓, β-catenin/ZEB1↓, ChemoSen↑,
96- QC,  docx,    Quercetin reverses docetaxel resistance in prostate cancer via androgen receptor and PI3K/Akt signaling pathways
- vitro+vivo, Pca, LNCaP - in-vitro, Pca, PC3
PI3K/Akt↓, Ki-67↓, BAX↑, Bcl-2↓, EpCAM↓, Twist↓, E-cadherin↑, P-gp/ABCB1↓, TumCP↓, TumCMig↓, TumCI↓,
88- QC,  PacT,    Quercetin Enhanced Paclitaxel Therapeutic Effects Towards PC-3 Prostate Cancer Through ER Stress Induction and ROS Production
- vitro+vivo, Pca, PC3
ROS↑, ER Stress↑, TumCP↓, Apoptosis↑, TumCCA↑, TumCMig↓, GRP78/BiP↑, CHOP/DDIT3↑, TumCG↓,
85- QC,    Quercetin inhibits invasion, migration and signalling molecules involved in cell survival and proliferation of prostate cancer cell line (PC-3)
- in-vitro, Pca, PC3
uPA↓, uPAR↓, EGFR↓, NRAS↓, Jun↓, NF-kB↓, β-catenin/ZEB1↓, p38↑, MAPK↑, cJun↓, cFos↓, Raf↓, TumCI↓, TumCMig↓,
82- QC,  ATG,    Arctigenin in combination with quercetin synergistically enhances the anti-proliferative effect in prostate cancer cells
- in-vitro, Pca, LNCaP
AR↓, PI3K/Akt↓, miR-21↓, STAT3↓, BAD↓, PRAS40↓, GSK‐3β↓, PSA↓, NKX3.1↑, Bax:Bcl2↑, miR-19b↓, miR-148a↓, AMPKα↓, TumCP↓, chemoPv↑, TumCMig↓,
156- Ralox,  Tam,  GEN,  CUR,    Modulators of estrogen receptor inhibit proliferation and migration of prostate cancer cells
- in-vitro, Pca, DU145 - in-vitro, Pca, PC3
ERβ/ESR2↑, TumCG↓, TumCMig↓, FAK↓, p38↓,
2441- RES,    Anti-Cancer Properties of Resveratrol: A Focus on Its Impact on Mitochondrial Functions
- Review, Var, NA
*toxicity↓, *BioAv↝, *Dose↝, *hepatoP↑, *neuroP↑, *AntiAg↑, *COX2/PTGS2↓, *antiOx↑, *ROS↓, *ROS↑, PI3K↓, Akt↓, NF-kB↓, Wnt↓, β-catenin/ZEB1↓, NRF2↑, GPx↑, HO-1↑, BioEnh?, PTEN↑, ChemoSen↑, eff↑, mt-ROS↑, Warburg↓, Glycolysis↓, GlucoseCon↓, GLUT1↓, lactateProd↓, HK2↓, EGFR↓, cMyc↓, ROS↝, MMPs↓, MMP7↓, survivin↓, TumCP↓, TumCMig↓, TumCI↓,
3086- RES,    Resveratrol inhibits the tumor migration and invasion by upregulating TET1 and reducing TIMP2/3 methylation in prostate carcinoma cells
- in-vitro, Pca, LNCaP - in-vitro, Pca, PC3 - in-vitro, Pca, DU145
TET1↑, TumCMig↓, TumCI↓, TIMP2↑, TIMP3↑, MMP2↓, MMP9↓,
3089- RES,    The Role of Resveratrol in Cancer Therapy
- Review, Var, NA
angioG↓, VEGF↓, EGFR↓, FGF↑, TumCMig↓, TumCI↓, TIMP1↑, MMP2↓, MMP9↓, NF-kB↓, Hif1a↓, PI3K↓, Akt↓, MAPK↓, EMT↓, AR↓,
3095- RES,    Resveratrol suppresses migration, invasion and stemness of human breast cancer cells by interfering with tumor-stromal cross-talk
- in-vitro, BC, NA
TumCP↓, TumCMig↓, TumCI↓, cycD1/CCND1↓, cMyc↓, MMP2↓, MMP9↓, SOX2↓, Akt↓, STAT3↓, α-SMA↓,
3072- RES,    Resveratrol ameliorates glioblastoma inflammatory response by reducing NLRP3 inflammasome activation through inhibition of the JAK2/STAT3 pathway
- in-vitro, GBM, LN229 - in-vitro, GBM, U87MG
tumCV↓, TumCP↓, TumCMig↓, Apoptosis↑, NLRP3↓, JAK2↓, STAT3↓, IL1β↓, IL18↓, IL6↓, TNF-α↓, Inflam↓,
3070- RES,    Resveratrol inhibits tumor progression by down-regulation of NLRP3 in renal cell carcinoma
- in-vitro, RCC, ACHN - in-vitro, RCC, 786-O - in-vivo, NA, NA
TumCP↓, TumCMig↓, TumCI↓, Apoptosis↑, NLRP3↓,
2988- RES,    The Antimetastatic Effects of Resveratrol on Hepatocellular Carcinoma through the Downregulation of a Metastasis-Associated Protease by SP-1 Modulation
- in-vitro, HCC, HUH7
TumCMig↓, TumCI↓, uPA↓, Sp1/3/4↓,
1747- RosA,    Molecular Pathways of Rosmarinic Acid Anticancer Activity in Triple-Negative Breast Cancer Cells: A Literature Review
- Review, BC, MDA-MB-231 - Review, BC, MDA-MB-468
TumCCA↑, TNF-α↑, GADD45A↑, BNIP3↑, survivin↓, Bcl-2↓, BAX↑, HH↓, Synergy↑, ChemoSen↑, RadioS↑, TumCP↓, TumCMig↓, Apoptosis↑, RenoP↑, CardioT↓,
3016- RosA,    Rosmarinic Acid Inhibits Cell Growth and Migration in Head and Neck Squamous Cell Carcinoma Cell Lines by Attenuating Epidermal Growth Factor Receptor Signaling
- in-vitro, HNSCC, UM-SCC-6 - in-vitro, HNSCC, UM-SCC-10B
chemoP↓, EGF↓, tumCV↓, TumCMig↓, ROS↓, PI3K↓, Akt↓, ERK↓, antiOx↑, p‑EGFR↓,
3027- RosA,    Rosmarinic acid inhibits proliferation and invasion of hepatocellular carcinoma cells SMMC 7721 via PI3K/AKT/mTOR signal pathway
- in-vitro, HCC, SMMC-7721 cell
TumCP↓, TumCCA↑, Apoptosis↑, EMT↓, TumCI↓, PI3K↓, Akt↓, mTOR↓, TumCMig↓, MMPs↓, Vim↓,
3008- RosA,    Rosmarinic acid decreases viability, inhibits migration and modulates expression of apoptosis-related CASP8/CASP3/NLRP3 genes in human metastatic melanoma cells
- in-vitro, Melanoma, SK-MEL-28
tumCV↓, TumCMig↓, ROS↓, Casp3↑, selectivity↑, Casp8↑, NLRP3↓,
3035- RosA,    Rosmarinic Acid Decreases the Malignancy of Pancreatic Cancer Through Inhibiting Gli1 Signaling
- in-vitro, PC, NA - in-vivo, NA, NA
Gli1↓, TumCCA↑, TumCMig↓, TumCI↓, CDK2↓, cycE/CCNE↓, P21↑, p27/CDKN1B↑,
1048- RosA,  GSL,    Rosmarinic acid in combination with ginsenoside Rg1 suppresses colon cancer metastasis via co-inhition of COX-2 and PD1/PD-L1 signaling axis
- in-vivo, Colon, MC38
TumCMig↓, TumCI↓, PD-1↓, COX2/PTGS2↓, PD-L1↓,
7375- RS,    Regulation of hippo signaling mediated apoptosis by Rauvolfia tetraphylla in triple-negative breast cancer
- in-vitro, BC, MDA-MB-231
eff↝, TumCCA↑, TumCMig↓, ROS↑, BAX↑, Mst1↑, Bcl-2↓, YAP/TEAD↓, LATS1↓,
1132- RT,    Rutin Promotes Proliferation and Orchestrates Epithelial–Mesenchymal Transition and Angiogenesis in MCF-7 and MDA-MB-231 Breast Cancer Cells
- in-vitro, BC, MDA-MB-231 - in-vitro, BC, MCF7
Vim↑, N-cadherin↑, E-cadherin↓, TumCP↑, TumCMig↑, tumCV↑, MKI67↑,
4900- Sal,    Anticancer Mechanisms of Salinomycin in Breast Cancer and Its Clinical Applications
- Review, BC, NA
CSCs↓, Apoptosis↑, TumAuto↑, necrosis↑, TumCP↓, TumCI↓, TumCMig↓, TumCG↓, TumMeta↓, eff↑, Bcl-2↓, cMyc↓, Snail↓, ALDH↓, Myc↓, AR↓, ROS↑, NF-kB↓, PTCH1↓, Smo↓, Gli1↓, GLI2↓, Wnt↓, mTOR↓, GSK‐3β↓, cycD1/CCND1↓, survivin↓, P21↑, p27/CDKN1B↑, CHOP/DDIT3↑, Ca+2↑, DNAdam↑, Hif1a↓, VEGF↓, angioG↓, MMP↓, ATP↓, p‑P53↑, γH2AX↑, ChemoSen↑,
5002- Sal,  SFN,    Salinomycin and Sulforaphane Exerted Synergistic Antiproliferative and Proapoptotic Effects on Colorectal Cancer Cells by Inhibiting the PI3K/Akt Signaling Pathway in vitro and in vivo
- in-vivo, CRC, Caco-2 - vitro+vivo, CRC, CX-1
Apoptosis↑, PI3K↓, Akt↓, P53↑, BAX↑, Bax:Bcl2↑, p‑PARP↑, TumCMig↓,
5127- Sal,    Salinomycin repressed the epithelial–mesenchymal transition of epithelial ovarian cancer cells via downregulating Wnt/β-catenin pathway
- in-vitro, Ovarian, NA
TumCI↓, E-cadherin↑, N-cadherin↓, Vim↓, Wnt↓, β-catenin/ZEB1↓, TumCP↓, TumCMig↓, EMT↓,
1209- SANG,    Sanguinarine is a novel VEGF inhibitor involved in the suppression of angiogenesis and cell migration
- in-vitro, Lung, A549
VEGF↓, TumCMig↓, Akt↓, p38↓,
6446- SAO,    Alpha-Santalol, a Component of Sandalwood Oil Inhibits Migration of Breast Cancer Cells by Targeting the β-catenin Pathway
- in-vitro, BC, NA
Wnt↓, β-catenin/ZEB1↓, TumCMig↓, Wound Healing↓,
6440- SAO,    Biological Properties of Sandalwood Oil and Microbial Synthesis of Its Major Sesquiterpenoids
- Review, Var, NA
AntiCan↑, *Bacteria↓, *antiOx↑, *Inflam↓, *ROS↓, AntiTum↑, TumCG↓, tumCV↓, β-catenin/ZEB1↓, TumCMig↓, chemoPv↑,
5139- SAS,    Sulfasalazine induces ferroptosis in osteosarcomas by regulating Nrf2/SLC7A11/GPX4 signaling axis
- in-vitro, OS, MG63 - in-vitro, OS, U2OS
*Inflam↓, TumCP↓, TumCMig↓, Apoptosis↑, Ferroptosis↑, Iron↑, MDA↑, ROS↑, GSH↓, SOD↓, MMP↓, NRF2↓, xCT/SLC7A11↓, GPx4↓, FTH1↓,
9278- SES, SSM,    Antitumor Effects of Sesamin via the LincRNA-p21/STAT3 Axis in Human Bladder Cancer: Inhibition of Metastatic Progression and Enhanced Chemosensitivity
- vitro+vivo, Bladder, UMUC3 - in-vitro, Bladder, 5637
tumCV↓, MMP2↓, STAT3↓, TumCMig↓, TumCI↓, ChemoSen↑, TumVol↓, TumW↓, Ki-67↓, Synergy↑,
3198- SFN,    Sulforaphane and TRAIL induce a synergistic elimination of advanced prostate cancer stem-like cells
- in-vitro, Pca, NA
Nanog↓, SOX2↓, E-cadherin↓, Snail↓, VEGFR2/KDR/Flk1↓, Diff↓, TumCMig↓, EMT↓, CXCR4↓, NOTCH1↓, ALDH1A1↓, CSCs↓, Synergy↑,
2166- SFN,    Sulforaphane targets cancer stemness and tumor initiating properties in oral squamous cell carcinomas via miR-200c induction
- in-vitro, Oral, NA - in-vivo, NA, NA
CSCs↓, selectivity↑, TumCMig↓, TumCI↓,
1136- SFN,    Sulforaphane inhibits epithelial-mesenchymal transition by activating extracellular signal-regulated kinase 5 in lung cancer cells
- in-vitro, Lung, NA - in-vivo, NA, NA
TumCMig↓, E-cadherin↑, ZO-1↑, N-cadherin↓, Snail↓, ERK5↑, EMT↓,
111- SFN,    Sulforaphene Interferes with Human Breast Cancer Cell Migration and Invasion through Inhibition of Hedgehog Signaling
- in-vitro, BC, SUM159
HH↓, Gli1↓, MMP2↓, MMP9↓, Smo↓, TumCMig↓, TumCI↓,
1466- SFN,    Sulforaphane inhibits thyroid cancer cell growth and invasiveness through the reactive oxygen species-dependent pathway
- vitro+vivo, Thyroid, FTC-133
TumCP↓, TumCCA↑, Apoptosis↑, TumCMig↓, TumCI↓, EMT↓, Slug↓, Twist↓, MMP2↓, MMP9↓, TumCG↓, p‑Akt↓, P21↑, ERK↑, p38↑, ROS↑, *toxicity∅, MMP↓, eff↓,
1462- SFN,    Epithelial-mesenchymal transition, a novel target of sulforaphane via COX-2/MMP2, 9/Snail, ZEB1 and miR-200c/ZEB1 pathways in human bladder cancer cells
- in-vitro, Bladder, T24/HTB-9
EMT↓, TumCI↓, TumCMig↓, E-cadherin↑, Zeb1↓, Snail↓, COX2/PTGS2↝, MMP2↝, MMP9↝,
1499- SFN,    Sulforaphane suppresses metastasis of triple-negative breast cancer cells by targeting the RAF/MEK/ERK pathway
- in-vitro, BC, NA
TumCMig↓, TumCI↓, FAK↓, p‑MEK↓, p‑ERK↓,
3306- SIL,  Rad,    Radioprotective and radiosensitizing properties of silymarin/silibinin in response to ionizing radiation
- Review, Var, NA
radioP↑, RadioS↑, TumCMig↓, TumCI↓, angioG↓, Apoptosis↑, DNAdam↓, ROS↑, *ROS↓, *Inflam↓,
3296- SIL,    Silibinin induces oral cancer cell apoptosis and reactive oxygen species generation by activating the JNK/c-Jun pathway
- in-vitro, Oral, Ca9-22 - in-vivo, Oral, YD10B
TumCP↓, TumCCA↑, ROS↑, SOD1↓, SOD2↓, *JNK↑, toxicity?, TumCMig↓, TumCI↓, N-cadherin↓, Vim↓, E-cadherin↑, EMT↓, P53↑, cl‑Casp3↑, cl‑PARP↑, BAX↑, Bcl-2↓, SOD↓,
3290- SIL,    A review of therapeutic potentials of milk thistle (Silybum marianum L.) and its main constituent, silymarin, on cancer, and their related patents
- Analysis, Var, NA
hepatoP↑, chemoP↑, *lipid-P↓, *antiOx↑, tumCV↓, TumCMig↓, Apoptosis↑, ROS↑, GSH↓, Bcl-2↓, survivin↓, cycD1/CCND1↓, NOTCH1↓, BAX↑, NF-kB↓, COX2/PTGS2↓, LOX1↓, iNOS↓, TNF-α↓, IL1↓, Inflam↓, *toxicity↓, CXCR4↓, EGFR↓, ERK↓, MMP↓, Cyt‑c↑, TumCCA↑, RB1↑, P53↑, P21↑, p27/CDKN1B↑, cycE/CCNE↓, CDK4↓, p‑pRB↓, Hif1a↓, cMyc↓, IL1β↓, IFN-γ↓, PCNA↓, PSA↓, CYP1A1↓,
3282- SIL,    Role of Silymarin in Cancer Treatment: Facts, Hypotheses, and Questions
- Review, Var, NA
hepatoP↑, AntiCan↑, TumCMig↓, Hif1a↓, selectivity↑, toxicity∅, *antiOx↑, *Inflam↓, TumCCA↑, P21↑, CDK4↓, NF-kB↓, ERK↓, PSA↓, TumCG↓, p27/CDKN1B↑, COX2/PTGS2↓, IL1↓, VEGF↓, IGFBP3↑, AR↓, STAT3↓, Telomerase↓, Cyt‑c↑, Casp↑, eff↝, HDAC↓, HATs↑, Zeb1↓, E-cadherin↑, miR-203↑, NHE1↓, MMP2↓, MMP9↓, PGE2↓, Vim↓, Wnt↓, angioG↓, VEGF↓, *TIMP1↓, EMT↓, TGF-β↓, CD44↓, EGFR↓, PDGF↓, *IL8↓, SREBP1/SREBF1↓, MMP↓, ATP↓, uPA↓, PD-L1↓, NOTCH↓, *SIRT1↑, SIRT1↓, CA↓, Ca+2↑, chemoP↑, cardioP↑, Dose↝, Half-Life↝, BioAv↓, BioAv↓, BioAv↓, toxicity↝, Half-Life↓, ROS↓, FAK↓,
3322- SIL,    Therapeutic intervention of silymarin on the migration of non-small cell lung cancer cells is associated with the axis of multiple molecular targets including class 1 HDACs, ZEB1 expression, and restoration of miR-203 and E-cadherin expression
- in-vitro, Lung, A549 - in-vitro, Lung, H1299 - in-vitro, Lung, H460
HDAC↓, HDAC1↓, HDAC2↓, HDAC3↓, HDAC8↓, HATs↑, Zeb1↓, E-cadherin↑, TumCMig↓,
3330- SIL,    Mechanistic Insights into the Pharmacological Significance of Silymarin
- Review, Var, NA
*neuroP↑, *hepatoP↑, *cardioP↑, *antiOx↓, *NLRP3↓, *NAD↑, ROS↓, NLRP3↓, TumCMig↓, *COX2/PTGS2↓, *iNOS↓, *MPO↓, *AChE↓, *LDH↓, *Telomerase↓, *Fas↓,
3326- SIL,    Silymarin suppresses proliferation of human hepatocellular carcinoma cells under hypoxia through downregulation of the HIF-1α/VEGF pathway
- in-vitro, Liver, HepG2 - in-vitro, Liver, Hep3B
*hepatoP↑, chemoPv↑, ChemoSen↑, TumCP↓, TumCMig↓, TumCI↓, Hif1a↓, VEGF↓, angioG↓,
1276- SIL,    Silibinin inhibits TPA-induced cell migration and MMP-9 expression in thyroid and breast cancer cells
- in-vitro, BC, NA - in-vitro, Thyroid, NA
TumCMig↓, MMP9↓, p‑MEK↓, p‑ERK↓,
1127- SIL,    Silibinin suppresses epithelial–mesenchymal transition in human non-small cell lung cancer cells by restraining RHBDD1
- in-vitro, Lung, A549
TumCP↓, TumCMig↓, TumCI↓, EMT↓, RHBDD1↓,
2417- SK,    Shikonin inhibits the Warburg effect, cell proliferation, invasion and migration by downregulating PFKFB2 expression in lung cancer
- in-vitro, Lung, A549 - in-vitro, Lung, H446
TumCP↓, TumCMig↓, TumCI↓, GlucoseCon↓, lactateProd↓, PFKFB2↓, Warburg↓, GLUT1∅, LDHA∅, PKM2∅, GLUT3∅, PDH∅,
2360- SK,    Shikonin inhibits growth, invasion and glycolysis of nasopharyngeal carcinoma cells through inactivating the phosphatidylinositol 3 kinase/AKT signal pathway
- in-vitro, NPC, HONE1 - in-vitro, NPC, SUNE-1
TumCP↓, Apoptosis↑, TumCMig↓, TumCI↓, GlucoseCon↓, lactateProd↓, ATP↓, PKM2↓, PI3K↓, Akt↓, MMP3↓, MMP9↓, TIMP1↑,
2355- SK,    Pharmacological properties and derivatives of shikonin-A review in recent years
- Review, Var, NA
AntiCan↑, TumCP↓, TumCMig↓, Apoptosis↑, TumAuto↑, Necroptosis↑, ROS↑, TrxR1↓, PKM2↓, RIP1↓, RIP3↓, Src↓, FAK↓, PI3K↓, Akt↓, mTOR↓, GRP58↓, MMPs↓, ATF2↓, cl‑PARP↑, Casp3↑, p‑p38↑, p‑JNK↑, p‑ERK↓,
2232- SK,    Shikonin Induces Autophagy and Apoptosis in Esophageal Cancer EC9706 Cells by Regulating the AMPK/mTOR/ULK Axis
- in-vitro, ESCC, EC9706
tumCV↓, TumCMig↓, TumCI↓, TumAuto↑, Apoptosis↑, Bcl-2↓, BAX↑, cl‑Casp3↑, cl‑Casp8↑, cl‑PARP↑, AMPK↑, mTOR↑, TumVol↓, OS↑, LC3I↑,

Showing Research Papers: 551 to 600 of 640
Prev Page 12 of 13 Next

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 640

Pathway results for Effect on Cancer / Diseased Cells:


NA, unassigned(tgid=0) ⓘ

NA↑, 2,   NA?, 1,  

Redox & Oxidative Stress(tgid=1) ⓘ

4-HNE↑, 1,   antiOx↓, 3,   antiOx↑, 5,   ARE↓, 1,   Catalase↓, 3,   Catalase↑, 1,   ENOX2↓, 1,   ENOX2↑, 1,   Fenton↑, 1,   GCLC↑, 1,   GPx↓, 1,   GPx↑, 2,   GPx1↓, 1,   GPx4↓, 11,   GSH↓, 23,   GSH↑, 4,   i-GSH↓, 1,   GSR↓, 1,   GSTs↑, 1,   H2O2↓, 2,   H2O2↑, 4,   HO-1↓, 6,   HO-1↑, 6,   Iron↑, 6,   i-Iron↑, 1,   Keap1↓, 1,   lipid-P↓, 4,   lipid-P↑, 9,   lipid-P↝, 1,   MDA?, 1,   MDA↓, 2,   MDA↑, 7,   i-MDA↑, 1,   NADH↓, 1,   NOX4↓, 1,   NRF2↓, 15,   NRF2↑, 12,   p‑NRF2↑, 1,   p66Shc↓, 1,   PYCR1↓, 1,   RNS↑, 1,   ROS?, 1,   ROS↓, 32,   ROS↑, 170,   ROS⇅, 2,   ROS↝, 3,   ROS∅, 1,   i-ROS↑, 1,   mt-ROS↑, 4,   SOD↓, 9,   SOD1↓, 1,   SOD2↓, 3,   SOD2↑, 1,   TAC↓, 3,   Trx↓, 2,   ox-Trx1↑, 1,   TrxR↓, 3,   TrxR1↓, 3,   xCT/SLC7A11↓, 4,  

Metal & Cofactor Biology(tgid=2) ⓘ

Ferritin↓, 1,   Ferritin↑, 1,   FTH1↓, 2,   IronCh↑, 1,   NCOA4↑, 1,   STEAP3↓, 1,   Tf↑, 1,  

Mitochondria & Bioenergetics(tgid=3) ⓘ

CDC2↓, 3,   CDC25↓, 4,   compI↓, 2,   compIII↓, 1,   compV↓, 1,   compV↓, 1,   EGF↓, 4,   ETC↓, 4,   HSP60/HSPD1↓, 1,   MFN2↓, 1,   mitResp↑, 1,   mtDam↑, 20,   OCR↓, 8,   OCR↑, 1,   OXPHOS↓, 4,   OXPHOS↑, 3,   PDH↓, 1,   PDH↑, 2,   PDH∅, 1,   PGC-1α↑, 1,   PINK1↑, 3,   SIRT3↓, 1,   SIRT3↑, 1,   VDAC1↓, 1,  

Core Metabolism/Glycolysis(tgid=4) ⓘ

12LOX↓, 2,   5LO↓, 1,   ACC↓, 2,   ACC-α↓, 1,   ACC1↓, 1,   ACLY↓, 2,   ACSL4↑, 1,   ALAT↓, 4,   ALDOA↓, 1,   AMPK↓, 1,   AMPK↑, 19,   AMPK↝, 1,   p‑AMPK↑, 6,   ATP↓, 17,   i-ATP↓, 1,   BMAL1↓, 1,   CAIX/CA9↓, 2,   citrate↓, 1,   ECAR↓, 7,   ENO1↓, 1,   FASN↓, 6,   FDG↓, 1,   G6PD↓, 2,   GALNT10↓, 1,   GAPDH↓, 2,   GlucoseCon↓, 11,   Glycolysis↓, 33,   Glycolysis↑, 1,   GSK‐3β↓, 7,   GSK‐3β↑, 2,   GSK‐3β↝, 1,   p‑GSK‐3β↓, 2,   Histones↑, 1,   ac‑Histones↑, 1,   HK1↓, 2,   HK2↓, 16,   HMG-CoA↓, 2,   IDH1↑, 1,   lactateProd↓, 14,   LDHA↓, 9,   LDHA∅, 1,   LDL↓, 1,   lipidLev↓, 1,   lipoGen↓, 2,   NADPH↓, 1,   O-Glc↓, 1,   PDHB↓, 1,   PDK1 / PDPK1↓, 7,   p‑PDK1 / PDPK1↓, 1,   PFK↓, 3,   PFK1↓, 1,   PFKFB3↓, 2,   PFKFB4?, 1,   PGK1↓, 2,   PGM1↓, 1,   PIP3↑, 1,   PKM2↓, 19,   PKM2∅, 1,   Pyruv↓, 1,   RARα↓, 1,   RARβ↑, 1,   RARγ↑, 1,   p‑S6↓, 1,   SCD1↓, 1,   SIRT1↓, 6,   SIRT1↑, 3,   SREBP1/SREBF1↓, 6,   TCA↓, 1,   TumCM/A↑, 1,   Warburg↓, 2,  

Cell Death(tgid=5) ⓘ

AIF↑, 4,   APAF1↑, 5,   Apoptosis↓, 9,   Apoptosis↑, 277,   mt-Apoptosis↑, 2,   ASC↑, 1,   BAD↓, 1,   BAD↑, 6,   Bak↑, 5,   BAX↓, 1,   BAX↑, 92,   BAX⇅, 1,   Bax:Bcl2↑, 20,   Bcl-2↓, 106,   Bcl-xL↓, 11,   BID↑, 1,   BIM↑, 2,   BNIP3↑, 2,   Casp↓, 2,   Casp↑, 19,   Casp↝, 1,   cl‑Casp↑, 1,   Casp1↓, 1,   Casp1↑, 2,   cl‑Casp1↑, 1,   Casp10∅, 1,   Casp12↑, 2,   cl‑Casp12↑, 1,   Casp2↑, 2,   Casp3↓, 1,   Casp3↑, 86,   cl‑Casp3↑, 32,   Casp7↑, 9,   cl‑Casp7↑, 1,   Casp8↑, 19,   Casp8∅, 1,   cl‑Casp8↑, 4,   proCasp8↑, 1,   Casp9↑, 45,   cl‑Casp9↑, 11,   CellShr↑, 2,   cFLIP↓, 4,   Cupro↑, 1,   Cyt‑c↓, 2,   Cyt‑c↑, 39,   mt-Cyt‑c↓, 1,   DR5↑, 9,   DR5∅, 1,   Endon↑, 1,   FADD↑, 2,   FADD∅, 1,   Fas↓, 2,   Fas↑, 9,   FasL↓, 1,   FasL↑, 1,   Ferroptosis↑, 20,   GRP58↓, 1,   GSDMD↑, 2,   IAP1↓, 5,   IAP2/BIRC3↓, 2,   iNOS↓, 9,   Mcl-1↓, 8,   Mcl-1↑, 1,   MDM2↓, 7,   MDM2↑, 1,   MOMP↓, 2,   MOMP↑, 3,   Necroptosis↑, 2,   necrosis↑, 3,   NOXA↑, 3,   p38↓, 5,   p38↑, 9,   p‑p38↓, 4,   p‑p38↑, 4,   p‑p38↝, 1,   PUMA↓, 1,   PUMA↑, 4,   Pyro↑, 2,   RIP3↓, 1,   survivin↓, 27,   TNFR 1↑, 2,   TRAIL↑, 1,   TRAIL⇅, 1,   TRAILR↑, 1,   TumCD?, 1,   TumCD↓, 2,   TumCD↑, 12,   TumCD∅, 1,   XIAP↓, 14,   YAP/TEAD↓, 6,   β-TRCP↑, 1,  

Kinase & Signal Transduction(tgid=6) ⓘ

ABL1↓, 1,   Akt?, 1,   Akt↓, 122,   Akt↑, 3,   Akt↝, 1,   p‑Akt↓, 54,   AKT1↓, 4,   AKT3↓, 1,   AMPKα↓, 1,   CaMKII ?, 1,   p‑CaMKII ↓, 1,   CK2↓, 3,   cMET↓, 1,   p‑cMET↑, 2,   CREB↓, 1,   EF-1α↓, 1,   EGFR↓, 28,   p‑EGFR↓, 2,   ERK↓, 38,   ERK↑, 7,   ERK↝, 2,   p‑ERK↓, 25,   p‑ERK↑, 1,   p‑ERK⇅, 1,   p‑ERK↝, 1,   ERK5↑, 1,   FGFR1↓, 3,   FGFR2↓, 1,   FGFR4/CD334↓, 1,   FOXD3↑, 1,   GRB2↓, 3,   HER2/EBBR2↓, 5,   HRAS↓, 1,   IGF-1R↓, 2,   IGFR↓, 1,   p‑IGFR↓, 1,   IKKα↓, 5,   IKKα↑, 1,   IKKα↝, 1,   p‑IKKα↓, 1,   IR↓, 2,   IκB↓, 1,   p‑IκB↓, 2,   p‑IκB↑, 1,   JAK↓, 5,   JAK↝, 1,   p‑JAK1↓, 1,   JAK2↓, 11,   p‑JAK2↓, 2,   JNK↓, 3,   JNK↑, 10,   JNK↝, 1,   p‑JNK↓, 4,   p‑JNK↑, 1,   p‑JNK↝, 1,   LATS1↓, 1,   p‑MAP2K1/MEK1↓, 1,   MAPK↓, 21,   MAPK↑, 8,   MAPK↝, 1,   p‑MAPK↓, 2,   p‑MAPK↑, 1,   MEK↓, 4,   p‑MEK↓, 3,   Mst1↑, 1,   mTOR?, 1,   mTOR↓, 61,   mTOR↑, 4,   mTOR↝, 1,   p‑mTOR↓, 16,   mTORC2↓, 2,   mTORC2↑, 1,   NRAS↓, 1,   OR13G1?, 1,   p‑p70S6↓, 1,   P70S6K↓, 6,   p‑P70S6K↓, 1,   p‑P90RSK↑, 1,   PFKFB2↓, 1,   PI3K?, 1,   PI3K↓, 87,   PI3K↑, 1,   PI3K↝, 1,   p‑PI3K↓, 17,   PI3K/Akt↓, 5,   PI3k/Akt/mTOR↓, 1,   PKA↓, 3,   PKCδ↓, 6,   PKCδ↑, 1,   PP2A↑, 1,   PRAS40↓, 1,   PRAS40↑, 1,   PTEN↓, 1,   PTEN↑, 15,   PTK2B / PYK2↓, 1,   Raf↓, 4,   c-Raf↓, 1,   RAS↓, 9,   RAS↑, 1,   RIP1↓, 3,   p‑S6K↓, 1,   SGK1↓, 1,   Sp1/3/4↓, 15,   Src↓, 4,   p‑Src↓, 1,   STAT↓, 2,   p‑STAT↓, 1,   STAT3↓, 56,   STAT3↑, 3,   p‑STAT3↓, 12,   p‑STAT3↑, 3,   i-STAT3↓, 1,   STAT5↓, 3,   STAT6↓, 2,   THEM4/CTMP↑, 1,   TSC2↑, 2,   p‑TSC2↑, 1,  

Transcription & Epigenetics(tgid=7) ⓘ

Ac-histone H3↑, 1,   ATF2↓, 2,   ATF3↑, 2,   ATF4↑, 6,   CBP↓, 1,   ChrMod↝, 1,   cJun↓, 6,   cJun↑, 1,   cMyc↓, 27,   DNMT1↓, 4,   DNMT1↑, 1,   DNMTs↓, 1,   EZH2↓, 4,   FOXM1↓, 7,   FOXO↑, 1,   FOXO1↓, 2,   FOXO1↑, 1,   FOXO3↓, 2,   FOXO3↑, 5,   FOXO4↓, 1,   FOXO4↑, 1,   H3↓, 1,   H3↑, 1,   ac‑H3↓, 1,   H4↑, 1,   ac‑H4↓, 1,   HATs↓, 2,   HATs↑, 3,   HDAC↓, 11,   HDAC1↓, 5,   HDAC2↓, 1,   HDAC3↓, 2,   HDAC4↓, 1,   HDAC6↓, 2,   HDAC8↓, 1,   HES1↓, 2,   JHDM1D-AS1↓, 1,   JPT1/HN1↓, 1,   LINC01116↓, 1,   Matr↓, 1,   miR-107↑, 1,   miR-10b-5p↓, 1,   miR-122-5p↑, 1,   miR-124-3p↓, 1,   miR-130a↓, 2,   miR-139-5p↑, 2,   miR-140↑, 1,   miR-143↑, 1,   miR-145↑, 1,   miR-148a↓, 1,   miR-155↓, 1,   miR-182-5p↓, 1,   miR-192-5p↑, 1,   miR-19b↓, 1,   miR-200c↑, 1,   miR-203↑, 1,   miR-205↑, 1,   miR-206↑, 1,   miR-21↓, 6,   miR-224↓, 1,   miR-25-5p↓, 1,   miR-29b↓, 1,   miR-30a-5p↑, 1,   miR-340↓, 1,   miR-34a↑, 7,   miR-375↑, 1,   miR-384↑, 1,   miR-422a↑, 1,   miR-542↓, 1,   miR-590-3p↑, 1,   miR-592↑, 1,   miR-99↑, 1,   MTA2↓, 1,   Myc↓, 2,   Myc↑, 1,   NDRG1↑, 1,   NR1D2↓, 1,   OCT4↓, 11,   other↓, 2,   other↑, 3,   other↝, 11,   PAX2↓, 1,   SBF2-AS1↓, 1,   SOX2↓, 9,   SOX4↓, 2,   SUV39H↓, 1,   TCF-4↓, 1,   TFAP2A↓, 1,   TLE1↓, 1,   tumCV↓, 98,   tumCV↑, 1,   tumCV∅, 1,   YMcells↓, 1,  

Protein Folding & ER Stress(tgid=8) ⓘ

CHOP/DDIT3↑, 14,   cl‑CHOP/DDIT3↑, 1,   CUL1↝, 1,   CUL5↝, 1,   eIF2α↓, 1,   eIF2α↑, 5,   p‑eIF2α↑, 1,   ER Stress↑, 24,   Erlin1↑, 1,   GRP78/BiP?, 1,   GRP78/BiP↓, 2,   GRP78/BiP↑, 8,   HSP70/HSPA5↓, 3,   HSP70/HSPA5↑, 1,   HSP90↓, 9,   HTRA↓, 1,   IRE1↑, 2,   PDI↑, 1,   PERK↑, 8,   p‑PERK↑, 1,   Proteasome↓, 2,   SERPINH1/HSP47↓, 1,   UPR↓, 1,   UPR↑, 4,  

Autophagy & Lysosomes(tgid=9) ⓘ

ATG13↑, 2,   ATG16L1↑, 1,   ATG3↑, 1,   ATG5↑, 2,   ATG7↑, 2,   Beclin-1/ATG6↓, 4,   Beclin-1/ATG6↑, 6,   CTSB↓, 1,   CTSD↓, 1,   LAMP2↓, 1,   LC3‑Ⅱ/LC3‑Ⅰ↓, 1,   LC3‑Ⅱ/LC3‑Ⅰ↑, 3,   LC3A↑, 1,   LC3B↓, 1,   LC3B↑, 1,   LC3B-II↓, 1,   LC3B-II↑, 2,   LC3I↑, 1,   LC3II↓, 2,   LC3II↑, 5,   LC3s↓, 1,   lysoMP↑, 2,   MitoP↑, 1,   p62↓, 3,   p62↑, 4,   p‑p62↑, 1,   PARK2↑, 3,   RUBCN↓, 1,   SESN2↑, 1,   TumAuto↓, 2,   TumAuto↑, 36,   TumAuto⇅, 1,   TumAuto↝, 1,   ULK1/ATG1↑, 1,  

DNA Damage & Repair(tgid=10) ⓘ

ATM?, 1,   ATM↑, 3,   ATR↑, 2,   BRCA1↓, 2,   BRCA1↑, 2,   BRCA2↑, 1,   DNA-PK↑, 1,   DNAdam↓, 1,   DNAdam↑, 36,   DNAdam⇅, 1,   DNArepair↓, 3,   ERCC1↓, 1,   ERCC3↑, 1,   hTERT/TERT↓, 3,   MGMT↓, 1,   NKX3.1↑, 1,   P53?, 1,   P53↓, 1,   P53↑, 58,   P53↝, 2,   P53∅, 1,   p‑P53↑, 3,   ac‑P53↑, 1,   i-P53↓, 1,   p73↑, 1,   PARP↓, 3,   PARP↑, 8,   p‑PARP↑, 2,   cl‑PARP↓, 1,   cl‑PARP↑, 39,   cl‑PARP1↑, 3,   PCNA↓, 22,   PCNA↑, 1,   RAD51↓, 1,   SIRT6↓, 1,   Telomerase↓, 6,   TOP1↓, 3,   TOP2↓, 1,   TOP2↑, 1,   TP53↑, 1,   XRCC1↓, 1,   γH2AX↑, 9,   γH2AX↝, 1,   p‑γH2AX↑, 1,  

Cell Cycle & Senescence(tgid=11) ⓘ

CC(CDKs/cyclins)↓, 1,   CDK1↓, 6,   CDK1↑, 1,   p‑CDK1↓, 1,   CDK2↓, 21,   CDK2↑, 3,   CDK4↓, 29,   CDK4↑, 3,   CDK4∅, 1,   CDK4/6↓, 1,   CDK6↓, 9,   CDK6↑, 3,   CDK6∅, 1,   CDKN1C/p57↓, 1,   CDKN1C/p57↑, 1,   CHK1↓, 2,   CHK1↑, 2,   p‑CHK1↑, 1,   Chk2↑, 2,   ChrCon↑, 1,   Cyc↓, 2,   cycA1/CCNA1↓, 8,   cycA1/CCNA1↑, 1,   CycB/CCNB1↓, 13,   cycD1/CCND1↓, 57,   cycD1/CCND1↑, 2,   cycD1/CCND1∅, 1,   CycD3↓, 1,   cycE/CCNE↓, 16,   E2Fs↓, 1,   GADD45A↑, 3,   Ki-67↓, 27,   MKI67↑, 1,   P21?, 1,   P21↓, 2,   P21↑, 39,   p27/CDKN1B↓, 2,   p27/CDKN1B↑, 13,   p‑pRB↓, 1,   RB1↑, 2,   p‑RB1↓, 2,   RRM2↓, 1,   Securin↓, 1,   TumCCA?, 1,   TumCCA↓, 6,   TumCCA↑, 171,   WEE1↑, 1,  

Proliferation, Differentiation & Cell State(tgid=12) ⓘ

4E-BP1↓, 2,   p‑4E-BP1↓, 2,   ALDH↓, 7,   ALDH1A1↓, 2,   AXIN1↑, 1,   BMI1↓, 3,   BMPs↑, 2,   CD133↓, 10,   CD24↓, 3,   cFos↓, 6,   CSCs↓, 37,   Diff↓, 1,   Diff↑, 2,   EIF4E↓, 1,   FGF↓, 3,   FGF↑, 1,   Gli↓, 1,   Gli1↓, 9,   GREM1↓, 1,   HH?, 1,   HH↓, 8,   IGF-1↓, 5,   IGFBP3↑, 2,   JAG1↓, 1,   Jun↓, 1,   Ki-67↓, 27,   Let-7↑, 2,   LRP6↓, 4,   p‑LRP6↓, 2,   MCM2↓, 1,   MSCmark↓, 1,   mTORC1↓, 4,   Nanog↓, 11,   Nestin↓, 3,   NOTCH↓, 8,   NOTCH↑, 1,   NOTCH1↓, 9,   NOTCH1↝, 1,   NOTCH3↓, 2,   OGFr↑, 2,   p300↓, 2,   PCLAF↓, 1,   Piezo1↑, 1,   PTCH1↓, 3,   PTCH2↓, 1,   Shh↓, 5,   Smo↓, 5,   Sufu↓, 1,   TAZ↓, 2,   TOPflash↓, 1,   TumCG?, 2,   TumCG↓, 124,   TumCG↑, 5,   TumCP?, 2,   TumCP↓, 293,   TumCP↑, 4,   tyrosinase↓, 2,   URGCP/URG4↓, 1,   WDR72↓, 1,   Wnt↓, 35,   Wnt/(β-catenin)↓, 6,   ZFX↓, 1,  

Migration(tgid=13) ⓘ

AGRN↓, 1,   AntiAg↑, 2,   AP-1↓, 3,   AP-1↝, 1,   CA↓, 1,   Ca+2↑, 25,   i-Ca+2↓, 1,   i-Ca+2↑, 1,   cal2↑, 1,   Cal9↑, 1,   Cav1↓, 1,   CCAT1↓, 1,   CCN2/CTGF↓, 2,   Cofilin↓, 1,   p‑Cofilin↑, 2,   COL1↓, 1,   COL1A1↓, 1,   COL3A1↓, 1,   CTNNB1↓, 1,   E-cadherin↓, 8,   E-cadherin↑, 83,   EM↑, 1,   EMT↓, 133,   EMT↑, 2,   EpCAM↓, 2,   F-actin↓, 4,   FAK↓, 17,   p‑FAK↓, 4,   Fibronectin↓, 5,   Galectin-9↓, 1,   GLI2↓, 2,   IQGAP3↓, 1,   ITGA2↓, 1,   ITGA5↓, 1,   ITGA6↓, 1,   ITGB1↓, 5,   ITGB3↓, 1,   ITGB4↓, 3,   ITGB6↓, 1,   KRAS↓, 2,   LEF1↓, 2,   LIMK2↓, 1,   LRP1↓, 1,   MALAT1↓, 1,   MET↓, 3,   MET↑, 3,   p‑MET↓, 1,   MMP-10↓, 1,   MMP1↓, 5,   MMP13↓, 3,   MMP14↓, 2,   MMP16↓, 1,   MMP17↓, 1,   MMP2?, 1,   MMP2↓, 121,   MMP2↝, 1,   MMP3↓, 9,   MMP7↓, 11,   MMP9?, 1,   MMP9↓, 132,   MMP9↑, 1,   MMP9↝, 1,   MMPs↓, 25,   MTA1↓, 2,   N-cadherin?, 1,   N-cadherin↓, 54,   N-cadherin↑, 2,   NCAM↓, 1,   NEDD9↓, 4,   PAI-1/SERPINE1↓, 1,   PAK1↓, 1,   pax↓, 1,   p‑pax↓, 1,   PDGF↓, 3,   Rac1↓, 2,   RHBDD1↓, 1,   Rho↓, 5,   Rho↑, 1,   ROCK1↓, 4,   ROCK1↑, 1,   Sharpin↓, 1,   Slug↓, 25,   Smad1↓, 3,   Smad1↑, 1,   Smad1↝, 1,   SMAD2↓, 3,   p‑SMAD2↓, 12,   SMAD3↓, 7,   p‑SMAD3↓, 10,   SMAD4↓, 2,   SMAD4↑, 1,   Snail↓, 42,   T-cadherin↑, 1,   TET1↑, 2,   TGF-β↓, 20,   TGF-β↑, 1,   TGF-β↝, 1,   TGF-β1↓, 4,   THBS1↓, 1,   TIMP1↓, 3,   TIMP1↑, 9,   TIMP2↓, 3,   TIMP2↑, 7,   TIMP3↑, 2,   pol-TregCell↓, 1,   TRIB3↑, 1,   TSC1↑, 1,   TSP-1↑, 2,   TumCA↓, 14,   TumCA↑, 2,   TumCI?, 2,   TumCI↓, 369,   TumCI↑, 4,   TumCMig?, 3,   TumCMig↓, 631,   TumCMig↑, 8,   TumCMig⇅, 1,   TumMeta↓, 70,   TumMeta↑, 3,   TumPF↓, 1,   Twist↓, 18,   TXNIP↑, 1,   uPA↓, 20,   uPAR↓, 6,   Vim↓, 65,   Vim↑, 2,   vinculin↓, 1,   Zeb1↓, 18,   Zeb1↑, 1,   ZEB2↓, 3,   α-SMA↓, 4,   α-SMA↑, 1,   α-tubulin↓, 1,   α-tubulin↑, 2,   ac‑α-tubulin↑, 1,   β-catenin/ZEB1↓, 61,   β-catenin/ZEB1↑, 3,   cl‑β-catenin/ZEB1↑, 1,  

Angiogenesis & Vasculature(tgid=14) ⓘ

angioG↓, 83,   angioG↑, 2,   CCN1/CYR61↓, 1,   CD31/PECAM-1↓, 4,   ECM/TCF↓, 1,   EGR1↓, 1,   EGR4↓, 1,   HIF-1↓, 6,   Hif1a↓, 48,   Hif1a↑, 2,   Hif1a↝, 1,   LOX1↓, 1,   NO↓, 2,   TXA2↓, 1,   VCAM-1↓, 4,   VEGF↓, 75,   VEGF↑, 1,   VEGFR1↓, 3,   VEGFR2/KDR/Flk1↓, 9,  

Barriers & Transport(tgid=15) ⓘ

ABCG1↓, 1,   AQPs↓, 3,   BBB↑, 2,   CLDN1↓, 2,   CLDN1↑, 1,   CLDN2↓, 1,   CX43/GJA1↓, 1,   EPR↑, 2,   GLUT1↓, 8,   GLUT1∅, 1,   GLUT2↓, 1,   GLUT3↓, 1,   GLUT3∅, 1,   MMP↓, 71,   MMP↑, 1,   MMP↝, 1,   MMP∅, 1,   MPT↑, 5,   NHE1↓, 1,   TRPM7↓, 2,   TRPM7↑, 1,   TRPV1↑, 3,   ZO-1↓, 1,   ZO-1↑, 5,  

Immune & Inflammatory Signaling(tgid=16) ⓘ

B2M↓, 1,   CD155↓, 2,   CD25+↓, 1,   CD25+↑, 1,   CD4+↓, 1,   CD4+↑, 3,   CD44↓, 12,   CD47↓, 1,   CD8+↑, 6,   COX1↓, 1,   COX2/PTGS2↓, 41,   COX2/PTGS2↑, 1,   COX2/PTGS2↝, 1,   CXCc↓, 1,   CXCL12↓, 1,   CXCR3↓, 1,   CXCR4↓, 9,   DR4↑, 3,   DR4∅, 1,   FOXP3↑, 1,   FoxP3+↓, 1,   Gal-3↓, 2,   HLA-I/II↑, 1,   HMGB1↓, 4,   ICAM-1↓, 7,   IFN-γ↓, 1,   IFN-γ↑, 1,   IL1↓, 3,   IL10↓, 1,   IL17↓, 1,   IL18↓, 5,   IL1α↓, 1,   IL1β↓, 12,   IL2↓, 2,   IL4↓, 1,   IL6↓, 18,   IL6↑, 1,   IL8↓, 5,   Imm↑, 12,   Imm↝, 1,   Inflam↓, 27,   Inflam↝, 1,   IRAK1↓, 1,   IRAK4↓, 1,   LIF↑, 1,   LTA/TNF-β↑, 1,   pol-M1↑, 1,   M2 MC↓, 1,   MCP1/CCL2↓, 3,   MIP-1β↑, 1,   NF-kB↓, 106,   NF-kB↑, 4,   NF-kB↝, 2,   p‑NF-kB↓, 3,   p‑NF-kB↑, 1,   NFKBIZ/IκBζ↓, 1,   NK cell↑, 3,   NLRP3↓, 8,   NLRP3↑, 2,   p65↓, 8,   p‑p65↓, 3,   PD-1↓, 2,   PD-L1↓, 8,   PD-L1↑, 3,   PD-L2↓, 1,   PGE2↓, 13,   PSA↓, 7,   T-Cell↑, 2,   TCF↓, 1,   Th1 response↑, 1,   Th17↑, 1,   TIGIT↓, 1,   TILs↑, 1,   TIM-3↓, 1,   TLR2↓, 1,   TLR4↓, 6,   TNF-α↓, 18,   TNF-α↑, 3,   TNFRSF25/DR3/APO3/LARD/TRAMP/WSL1↑, 1,   TRADD↑, 1,   Treg lymp↓, 1,  

Cellular Microenvironment(tgid=17) ⓘ

GFAP↓, 1,   GGT/CD224↓, 1,   pH↑, 1,   TAMS↓, 2,  

Synaptic & Neurotransmission(tgid=18) ⓘ

PTN↓, 1,  

Hormonal & Nuclear Receptors(tgid=20) ⓘ

AhR↓, 2,   AhR↑, 1,   AhR↓, 2,   AR↓, 7,   AR↑, 1,   CYP19↓, 1,   ER-α36↓, 2,   ERβ/ESR2↑, 1,   Estro↝, 1,   NR3C2/MR↑, 2,   PPARα↑, 1,   PPARα↝, 1,   PPARγ↑, 4,   RANKL↓, 1,  

Drug Metabolism & Resistance(tgid=21) ⓘ

ABCG2↓, 3,   AKR1B10↓, 1,   BioAv↓, 22,   BioAv↑, 23,   BioAv↝, 5,   BioEnh?, 1,   BioEnh↑, 1,   chemoR↓, 1,   ChemoSen↓, 1,   ChemoSen↑, 108,   CompStab↓, 1,   CompStab↑, 1,   CYP1A1↓, 2,   CYP1A1↑, 1,   CYP1A2↑, 1,   CYP1B1↓, 1,   CYP2A3/CYP2A6↓, 1,   CYP2E1↑, 1,   CYP3A4↓, 1,   DDS↑, 1,   Dose?, 5,   Dose↓, 6,   Dose↑, 2,   Dose↝, 51,   Dose∅, 5,   eff↓, 26,   eff↑, 45,   eff↝, 8,   GSTP1/GSTπ↓, 1,   Half-Life↓, 5,   Half-Life↑, 1,   Half-Life↝, 6,   MDR1↓, 1,   MRP1/ABCC1↓, 1,   NAT↓, 1,   P-gp/ABCB1↓, 10,   P450↓, 2,   RadioS↑, 26,   selectivity?, 2,   selectivity↑, 75,   Synergy?, 1,   Synergy↑, 59,  

Clinical Biomarkers(tgid=22) ⓘ

AFP?, 1,   AFP↓, 1,   ALAT↓, 4,   ALB↑, 1,   ALP↓, 2,   AR↓, 7,   AR↑, 1,   AST?, 1,   AST↓, 3,   B2M↓, 1,   BMD↑, 1,   BRCA1↓, 2,   BRCA1↑, 2,   DBIL↓, 1,   EGFR↓, 28,   p‑EGFR↓, 2,   EZH2↓, 4,   Ferritin↓, 1,   Ferritin↑, 1,   FOXM1↓, 7,   HER2/EBBR2↓, 5,   hTERT/TERT↓, 3,   IBIL↓, 1,   IL6↓, 18,   IL6↑, 1,   KRAS↓, 2,   LDH↓, 7,   LDH↑, 1,   Maspin↑, 1,   Myc↓, 2,   Myc↑, 1,   PD-L1↓, 8,   PD-L1↑, 3,   PSA↓, 7,   TBIL↓, 1,   TP53↑, 1,   TRIB3↑, 1,   Tumccf↓, 5,  

Functional Outcomes(tgid=23) ⓘ

AntiCan↓, 2,   AntiCan↑, 41,   AntiCan∅, 1,   antiD↑, 1,   AntiDiabetic↑, 2,   antiNeop↑, 2,   AntiTum↓, 1,   AntiTum↑, 23,   cachexia↓, 2,   cardioP↑, 3,   CardioT↓, 1,   chemoP?, 1,   chemoP↓, 1,   chemoP↑, 22,   chemoPv↑, 12,   ChemoSideEff↓, 2,   fatigue↓, 1,   FTO↓, 1,   FTO↑, 1,   hepatoP↑, 5,   motorD↑, 1,   Mucositis↓, 1,   neuroP↑, 3,   NP/CIPN↓, 1,   Obesity↓, 1,   OS↑, 16,   PFS↑, 1,   Pin1↓, 1,   QoL↑, 3,   radioP↑, 9,   RenoP↑, 3,   Risk↓, 11,   Risk↑, 1,   Sleep↑, 1,   toxicity?, 1,   toxicity↓, 16,   toxicity↑, 2,   toxicity↝, 3,   toxicity∅, 2,   TumNum↓, 1,   TumVol↓, 39,   TumVol↑, 1,   TumW↓, 16,   Weight∅, 2,   Wound Healing↓, 3,   Wound Healing↑, 1,  

Infection & Microbiome(tgid=24) ⓘ

AntiBio↑, 1,   Bacteria↓, 2,   GutMicro↑, 4,   Sepsis↓, 1,  

Ingredients & Constituents(tgid=25) ⓘ

Ingr↝, 8,  
Total Targets: 1086

Pathway results for Effect on Normal Cells:


Redox & Oxidative Stress(tgid=1) ⓘ

antiOx↓, 4,   antiOx↑, 63,   Bil↓, 1,   Catalase↑, 20,   Fenton↓, 1,   GPx↑, 16,   GPx1↑, 3,   GPx4↑, 1,   GSH↑, 15,   GSR↑, 2,   GSTs↑, 7,   H2O2↓, 1,   HDL↓, 1,   HDL↑, 3,   HO-1?, 1,   HO-1↓, 1,   HO-1↑, 8,   hyperG↝, 1,   Keap1↓, 2,   Keap1↑, 1,   lipid-P↓, 18,   MDA↓, 11,   MPO↓, 5,   NADH↓, 1,   NOX↓, 1,   NOX4↓, 1,   NQO1↑, 2,   NRF2↑, 20,   RNS↓, 4,   ROS?, 1,   ROS↓, 50,   ROS↑, 1,   SAM-e↑, 1,   SOD↑, 20,   SOD1↑, 6,   SOD2↑, 1,   TAC↑, 2,   TBARS↓, 3,   VitE↓, 1,  

Metal & Cofactor Biology(tgid=2) ⓘ

IronCh↑, 1,  

Mitochondria & Bioenergetics(tgid=3) ⓘ

compII↑, 1,   compIII↑, 1,   HSP60/HSPD1↓, 1,   mitResp↓, 1,   OXPHOS↓, 1,   PGC-1α↑, 1,   SIRT3↑, 1,  

Core Metabolism/Glycolysis(tgid=4) ⓘ

5LO↓, 2,   ALAT↓, 7,   ATP↑, 1,   ATP↝, 1,   glucose↓, 3,   glucose↑, 1,   glucose↝, 2,   GlucoseCon↑, 1,   Glycolysis↑, 1,   GSK‐3β↓, 1,   H2S↑, 1,   HK2↑, 1,   HMG-CoA↓, 1,   LDL↓, 5,   NAD↑, 1,   NAD↝, 1,   NADPH↓, 2,   PFKL↑, 1,   PFKM↑, 1,   PKM2↑, 1,   SIRT1↑, 1,  

Cell Death(tgid=5) ⓘ

Apoptosis↓, 2,   BAX↓, 1,   Bcl-2↑, 1,   Bcl-xL↑, 1,   Casp1↓, 1,   Casp12↓, 1,   Casp3↓, 5,   cl‑Casp3↓, 1,   cl‑Casp8↓, 1,   Casp9↓, 2,   Fas↓, 2,   GranB/GZMB↓, 1,   iNOS↓, 11,   p38↓, 1,   survivin↓, 1,  

Kinase & Signal Transduction(tgid=6) ⓘ

Akt↓, 1,   Akt↑, 4,   p‑Akt↑, 1,   CREB↑, 1,   ERK↓, 2,   p‑ERK↑, 1,   HGF/c-Met↑, 1,   IKKα↑, 1,   JAK2↑, 1,   JNK↑, 1,   p‑JNK↓, 1,   MAPK↓, 5,   mTOR↓, 2,   mTOR↑, 2,   PI3K↓, 1,   PI3K↑, 4,   PTEN↑, 1,   RIP1↓, 1,   STAT3↓, 1,   STAT3↑, 2,   p‑STAT3↑, 1,  

Transcription & Epigenetics(tgid=7) ⓘ

AntiThr↑, 3,   ATF4↓, 1,   HOTAIR↑, 1,   other↓, 2,   other↑, 3,   other↝, 6,   tumCV↓, 1,   tumCV↑, 1,  

Protein Folding & ER Stress(tgid=8) ⓘ

CHOP/DDIT3↓, 2,   CHOP/DDIT3↑, 1,   p‑eIF2α↓, 1,   ER Stress↓, 2,   GRP78/BiP↓, 1,   GRP78/BiP↑, 1,   GRP94↑, 1,   HSP70/HSPA5↓, 1,   XBP-1↓, 1,  

Autophagy & Lysosomes(tgid=9) ⓘ

LC3‑Ⅱ/LC3‑Ⅰ↑, 1,  

DNA Damage & Repair(tgid=10) ⓘ

p‑BRCA1↑, 1,   DNAdam↓, 2,   Telomerase↓, 1,  

Proliferation, Differentiation & Cell State(tgid=12) ⓘ

BMPs↑, 1,   Diff↝, 1,   neuroG↑, 1,   TumCP↓, 2,  

Migration(tgid=13) ⓘ

AntiAg↑, 5,   Ca+2↑, 1,   Ca+2↝, 2,   cal2↓, 1,   E-cadherin↑, 1,   F-actin↓, 1,   MMP9↓, 1,   N-cadherin↓, 1,   PAI-1/SERPINE1↓, 1,   p‑Rac1↓, 1,   Rho↓, 1,   serineP↓, 1,   Snail↓, 1,   TGF-β↑, 1,   TIMP1↓, 1,   TumCI↓, 1,   TumCI∅, 1,   TumCMig↓, 3,   TumCMig↑, 1,   TumCMig∅, 1,   Vim↓, 1,  

Angiogenesis & Vasculature(tgid=14) ⓘ

angioG↓, 2,   E-sel↓, 1,   NO↓, 4,   VEGF↓, 1,   VEGF↑, 1,  

Barriers & Transport(tgid=15) ⓘ

BBB↓, 1,   BBB↑, 4,   GastroP↑, 2,   GLUT1↑, 1,   GLUT2↑, 1,   IBI↑, 4,   MMP↑, 1,   MUC5AC↓, 1,   TRPV1↑, 1,   VGSC↓, 1,   ZO-1↑, 1,  

Immune & Inflammatory Signaling(tgid=16) ⓘ

CCL11↓, 1,   CD25+↑, 1,   CD4+↑, 2,   COX1↓, 1,   COX2/PTGS2↓, 13,   FOXP3↑, 1,   HMGB1↓, 1,   ICAM-1↓, 1,   IFN-γ↓, 4,   IL1↓, 1,   IL10↓, 2,   IL10↑, 2,   IL12↓, 1,   IL17↓, 1,   IL1β↓, 13,   IL23↓, 1,   IL4↓, 1,   IL4↑, 1,   IL6↓, 16,   IL8↓, 1,   Imm↑, 6,   Inflam?, 1,   Inflam↓, 63,   Inflam↑, 2,   IRF3↓, 1,   LPS↓, 1,   M2 MC↑, 1,   MCP1/CCL2↓, 2,   MyD88↓, 1,   NeuroI↓, 1,   NF-kB↓, 18,   NLRP3↓, 5,   PGE2↓, 5,   RAGE↓, 1,   SOCS-3↓, 1,   TLR2↓, 2,   TLR4↓, 5,   TNF-α↓, 20,   Treg lymp↝, 1,   VitD↑, 1,  

Cellular Microenvironment(tgid=17) ⓘ

pH↑, 1,  

Synaptic & Neurotransmission(tgid=18) ⓘ

5HT↓, 1,   Ach↑, 1,   AChE↓, 6,   AChE↑, 1,   BChE↓, 2,   BDNF↑, 3,   ChAT↑, 1,   GABA↑, 1,   MAOA↓, 1,   NGF↑, 1,   TPH1↓, 1,  

Protein Aggregation(tgid=19) ⓘ

AGEs↓, 3,   APP↓, 1,   Aβ↓, 9,   BACE/β-secretase↓, 3,   p‑tau↓, 2,   XO↓, 1,  

Hormonal & Nuclear Receptors(tgid=20) ⓘ

AHR↓, 1,   PPARγ↓, 1,   PPARγ↑, 3,   testos↑, 1,   VDR↑, 1,  

Drug Metabolism & Resistance(tgid=21) ⓘ

BioAv↓, 17,   BioAv↑, 23,   BioAv⇅, 1,   BioAv↝, 15,   CompStab↝, 1,   CYP1A1↑, 1,   CYP1A2↑, 1,   Dose↓, 1,   Dose↑, 2,   Dose↝, 8,   eff↑, 7,   Half-Life↓, 3,   Half-Life↝, 5,   Half-Life∅, 1,   P-gp/ABCB1↓, 1,   P450↓, 2,   selectivity↑, 1,   Synergy↑, 4,  

Clinical Biomarkers(tgid=22) ⓘ

ALAT↓, 7,   ALP↓, 3,   AST↓, 7,   Bil↓, 1,   BMD↑, 1,   BP↓, 4,   p‑BRCA1↑, 1,   BUN↓, 1,   Calcium↑, 1,   CEA↓, 1,   creat↓, 3,   hs-CRP↓, 1,   IL6↓, 16,   LDH↓, 5,   Mag↑, 1,   NOS2↓, 1,   RAGE↓, 1,   SpO2↑, 1,   Urea↓, 2,   VitD↑, 1,  

Functional Outcomes(tgid=23) ⓘ

Analgesic↑, 1,   AntiAge↑, 1,   antiAll↑, 9,   AntiArt↑, 6,   AntiCan↓, 1,   AntiCan↑, 11,   antiCG↑, 1,   antiD↓, 1,   AntiDiabetic↑, 14,   antiPs↑, 1,   AntiTum↑, 4,   cardioP↑, 20,   chemoP↑, 2,   chemoPv↑, 3,   ChemoSideEff↓, 1,   cognitive↓, 1,   cognitive↑, 9,   diuretic↑, 1,   hepatoP↑, 21,   Learn↑, 1,   memory↑, 11,   neuroP?, 1,   neuroP↑, 40,   Obesity↓, 5,   OS↑, 2,   Pain↓, 1,   QoL↑, 1,   radioP↑, 1,   RenoP↑, 5,   Risk↓, 1,   Stroke↓, 6,   toxicity↓, 25,   toxicity↑, 2,   toxicity↝, 7,   toxicity∅, 8,   Weight↑, 1,  

Infection & Microbiome(tgid=24) ⓘ

AntiBio↑, 5,   AntiFungal↑, 1,   AntiP↑, 1,   AntiViral↑, 5,   Bacteria↓, 17,   GutMicro↑, 12,   Sepsis↓, 2,  

Ingredients & Constituents(tgid=25) ⓘ

Ingr↝, 4,  
Total Targets: 311

Scientific Paper Hit Count for: TumCMig, Tumor cell migration
21 Curcumin
15 Quercetin
15 Matrine
13 Honokiol
13 Shikonin
11 Berberine
11 Luteolin
11 Magnolol
10 Capsaicin
10 Fisetin
10 Magnetic Fields
9 Apigenin (mainly Parsley)
9 Resveratrol
9 EGCG (Epigallocatechin Gallate)
9 Dandelion Root
9 Sulforaphane (mainly Broccoli)
9 Silymarin (Milk Thistle) silibinin
8 Betulinic acid
7 Ashwagandha(Withaferin A)
7 Benzyl isothiocyanate
7 Thymoquinone
7 Kaempferol
7 Licochalcone A
7 Melatonin
7 Urolithin
6 Propolis -bee glue
6 Chlorogenic acid
6 Metformin
6 Diindolylmethane
6 Ferulic acid
6 Isorhamnetin
6 Piperlongumine
6 Rosmarinic acid
5 Silver-NanoParticles
5 Alpha-Lipoic-Acid
5 Artemisinin
5 Baicalein
5 Radiotherapy/Radiation
5 Carvacrol
5 Indole-3-carbinol
5 Emodin
5 Eugenol
5 Ginkgetin
5 Hyperoside
5 Cisplatin
5 L-Theanine
5 Licorice
5 Phenethyl isothiocyanate
5 Piperine
4 Astragalus
4 Gemcitabine (Gemzar)
4 Astaxanthin
4 Boron
4 Paclitaxel/Taxol
4 NTP, Non-Thermal Plasma,Cold Atmospheric Plasma
4 5-fluorouracil
4 Gallic acid
4 Ginkgolide B
4 Isoliquiritigenin
4 Ivermectin
4 Juglone
4 Morin
4 Nimbolide
4 Pterostilbene
3 DTS(dibenzyl trisulphide) from Anamu
3 Berbamine
3 Bacopa monnieri
3 brusatol
3 Caffeic acid
3 Chrysin
3 Cinnamon
3 Crocetin
3 Copper and Cu NanoParticles
3 Cucurbitacin
3 CUSP9
3 Deguelin
3 Evodiamine
3 Formononetin
3 Fucoidan
3 Garcinol
3 Hydrogen Gas
3 Hibiscus sabdariffa
3 HydroxyTyrosol
3 Linalool
3 Lycopene
3 mebendazole
3 Methylsulfonylmethane
3 Mushroom Lion’s Mane, Hericium erinaceus
3 Mushroom Maitake
3 Marjoram (Origanum majorana)
3 Patchouli Oil (Pogostemon cablin)
3 Phycocyanin
3 salinomycin
3 Aflavin-3,3′-digallate
2 1,8-Cineole
2 3-bromopyruvate
2 Allicin (mainly Garlic)
2 Andrographis
2 Fennel Oil/Foeniculum vulgare
2 Isovitexin
2 Aspirin
2 Arctigenin
2 Baicalin
2 Beta-Caryophyllene
2 Bufalin/Huachansu
2 Genistein (soy isoflavone)
2 Boswellia (frankincense)
2 Carnosic acid
2 Celecoxib
2 Celastrol
2 Centella asiatica / Gotu kola → asiaticoside
2 chaetocin
2 Chlorophyllin
2 Docetaxel
2 Carvone
2 Disulfiram
2 Ellagic acid
2 Ginkgo biloba-EGb 761
2 Ginkgolic acids
2 Ginkgo biloba
2 Geraniol
2 Grapeseed extract
2 phytic acid, Inositol hexakisphosphate
2 isoflavones
2 isoorientin
2 isoquercitrin
2 itraconazole
2 doxorubicin
2 Plumbagin
2 low dose naltrexone
2 Lutein
2 Methyl Jasmonate
2 Magnetic Field Rotating
2 Magnesium
2 Mangiferin
2 tamoxifen
2 Mushroom Chaga, Inonotus obliquus
2 Psoralidin
2 Parthenolide
2 α-Santalol/Sandalwood oil
2 Ursolic acid
2 Vitamin C (Ascorbic Acid)
2 VitK3,menadione
1 Auranofin
1 Allyl isothiocyanate
1 Ajoene (compound of Garlic)
1 Phyllanthus emblica/Emblica officinalis/Amla / Indian Gooseberry
1 Anethole/trans-Anethole
1 Atorvastatin
1 Aloe anthraquinones
1 Biochanin A
1 Bevacizumab (brand Avastin)
1 Brucea javanica
1 Bromelain
1 selenomethionine
1 Black Rice, Oryza sativa
1 Bruteridin(bergamot juice)
1 α-Bisabolol / Chamomile oil
1 Butyrate
1 Caffeic Acid Phenethyl Ester (CAPE)
1 Cannabidiol
1 chitosan
1 Selenium NanoParticles
1 Hydroxycinnamic-acid
1 Citric Acid
1 Oxaliplatin
1 Electrical Pulses
1 Cynaropicrin
1 Cysteamine
1 Dichloroacetophenone(2,2-)
1 Dasatinib/Phyrago
1 Diclofenac
1 Date Fruit Extract
1 Docosahexaenoic Acid
1 diet Short Term Fasting
1 D-limonene
1 Mistletoe/Viscum album Extracts
1 Tetrahydroxystilbene glucoside
1 eicosapentaenoic acid
1 erastin
1 Eurycomanone
1 Shilajit/Fulvic Acid
1 olaparib/LYNPARZA
1 Galloflavin
1 Gambogic Acid
1 Ginger/6-Shogaol/Gingerol
1 Ginseng
1 γ-linolenic acid (Borage Oil)
1 Gossypol/AT-101
1 Graviola
1 Proanthocyanidins
1 HydroxyCitric Acid
1 Hops (Humulus lupulus)
1 Isobavachalcone
1 carboplatin
1 Isothiocyanates
1 Lapachol
1 Lasiodin
1 Lactoferrin/Talactoferrin
1 SDG/lignans
1 Modified Citrus Pectin
1 Methyl salicylate / Sweet Birch oil
1 immunotherapy
1 Lemon Balm/Melissa officinalis
1 Moringa oleifera
1 Myricetin
1 Naringin
1 Niclosamide (Niclocide)
1 Oroxylin-A
1 Orlistat
1 Propyl gallate
1 temozolomide
1 raloxifen
1 Germacranolide sesquiterpene lactone
1 Rauwolfia serpentina/Indian Snakeroot
1 Rutin
1 Sanguinarine
1 Sulfasalazine
1 Sesamin
1 Spirulina(Arthrospira/Limnospira)
1 Selenite (Sodium)
1 Terpinen-4-ol / Tea Tree Oil
1 Thymol-Thymus vulgaris
1 Usnic acid
1 Arsenic trioxide
1 Vitexin
1 Walnut
1 Zinc
1 β‐Elemene
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:%  IllCat:%  CanType:%  Cells:%  prod#:%  Target#:326  State#:%  Dir#:%
wNotes=0 sortOrder:rid,rpid

 

Home Page